A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.
Investors anticipate “bounce-back” in European private investment – Pharmaceutical Technology
Share this article At the Swiss Biotech Day conference, experts anticipated a recovery in the investment market. Credit: Scharvik via Getty Images The Swiss biotech